NOW ONLINE
@DalsgaardKarina & team at @AarhusUni unveil the potential of liquid biopsies for detailed genomic analysis in advanced/aggressive #ProstateCancer. A promising alternative to traditional tissue biopsies!
🔓OPEN ACCESS
➡️https://t.co/U9muxx1Hf9
Is there a way for prognostic tools to distinguish between indolent and aggressive #ProstateCancer (PC)?
A Aarhus University Hospital (@AUHdk) team demonstrates the potential of stromal signatures in the identification of clinically relevant PC subtypes.
https://t.co/ajsLfE0Xr5
Postdoc wanted!
Two-year postdoc position in liquid tumor biopsy sequencing and prostate cancer (epi)genomics in Sørensen group @DalsgaardKarina.
Application deadline: March 25th
https://t.co/50BS2aO9Ir
Lav-risiko prostatakræft kan alligevel ende med at kræve operation i op til hver tredje patient.
@EvaFerlev vil udvikle en molekylær risiko-signatur for at kunne skræddersye den rigtige behandling og overvågning.
Tak til NEYE-fonden for støtte!🙏
Læs mere:
https://t.co/97RHb5d9vv
Our study on the impact of germline DNA repair gene variants on the prognosis and treatment of men with advanced #prostatecancer has now been published.
@EmmaBollmann@DalsgaardKarina
https://t.co/ucq6mxNPcl
Happy to share that the results from the PRIMA trial have just been published. It is the culmination of a project that involved more than 2000 patients, where we tested if the STHLM3 test would be a better for detection of prostate cancer than PSA. https://t.co/tQj0R4jNxm
A new study from @DalsgaardKarina & co-workers shows that loss of PARP1, ARH3, YWHAE or UBR5 is associated with PARP inhibitor resistance in castration resistant #ProstateCancer.
👉 https://t.co/uj8GypzwGl
Dr. Karina Dalsgaard (@DalsgaardKarina) and colleagues from @AarhusUni_int used a genome-wide #CRISPR-Cas9 knockout 🥊 screen to identify genes involved in poly(ADP-ribose) polymerase inhibitor resistance in castration-resistant prostate cancer.
https://t.co/K8TzAtW1Qp
Our study on the use of non-negative matrix factorization on circulating tumor DNA is out in elife! w @SBesenbacher @moma_dk@DTU_HealthTech https://t.co/uMhJ6F2LWz
Vi tilbyder stilling(er) som klinisk akademiker @DkDska i vores diagnostiske gruppe til fortolkning af somatiske varianter i targeteret kræftbehandling og kliniske #ctDNA analyser. Ansøgningsfrist 20.2.
https://t.co/DO1M00yyf0
Exciting #prostatecancer research double feature! @DalsgaardKarina and co @AarhusUni_int present TWO new manuscripts investigating 1) the prostate tumor #microbiome and 2) the
prostate cancer #circRNA landscape.
Read here!
1) https://t.co/NUHh5mwmBY
2) https://t.co/ThANo6TBpe
Ny professor: Vi kan diagnosticere prostatakræft tidligere
@DalsgaardKarina på @AUHdk går fra et MSO professorat til et fuldt professorat på @AarhusUni. Hun forsker i nye metoder til at diagnosticere prostatakræft og målrette behandlingen.
#sundpol#dkvid
https://t.co/0pUERtoXa8